MedPath

Evaluating the effect of metformine on antimullerian hormone(AMH ) in polycystic ovarian syndrome –a clinical trial

Not Applicable
Conditions
Polycystic ovarian syndrome.
Registration Number
IRCT2014081918858N1
Lead Sponsor
Diabet Research Center, Yazd Shahid Sadoughi Univercity Of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
42
Inclusion Criteria

1-age between 18-45 2- patienst without cardiovascular. renal and hepatic disease 3- patients must be new cases
exclusion criteria: 1- use of oral anticoagulant drug during study 2-stop using metformine during study 3-pregnancy 4-body mass index below eighteen 5- sever hirsutism 6-amenorrhea7-use of clomiphene citrate or other ovulation induction drugs 8-cushing syndrome 9- using drugs that cause hirsutism 10- congenital adrenal hyperplasia 11- hypothyroidism 12- androgen producing ovarian tumors 13- prolactinoma 14- diabet

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath